“Substantial contribution of extrinsic risk factors to cancer development” was published December 16 in Nature
Patients with high-risk B-ALL are most likely to relapse after treatment
ORNL researchers develop smart data tool to accelerate literature-based discovery
Team finds that cancer cells can actually cause neighboring normal cells to become cancerous
New technique efficiently captures and grows tumor cells to guide selection of drug therapy
“It’s simple enough that one could teach an undergrad to do it in a week,” professor says
A quick overview of the latest developments in and issues surrounding pancreatic and lung cancer research
MD Anderson study also finds individuals with certain genetic variations more vulnerable to dietary risk
Scientists are developing a unique targeting and delivery system that uses a peptide, or amino acid chain, to seek and destroy cancer cells
Parietin, also known as physcion, could slow the growth of and kill human leukemia cells obtained directly from patients
CURRENT ISSUE - October 2025
Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature